Sarah Cannon Cancer Center - (Colorado Blood Cancer Institute) — Denver, Colorado

Sarah Cannon Cancer Center - (Colorado Blood Cancer Institute) is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Sarah Cannon Cancer Center - (Colorado Blood Cancer Institute) has participated in 1 clinical trials.

Therapeutic areas: Relapsed/Refractory Multiple Myeloma (RRMM), Metastatic Colorectal Cancer (mCRC), Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Sponsors: Karyopharm Therapeutics Inc.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Cancer Center - (Colorado Blood Cancer Institute)?

Sarah Cannon Cancer Center - (Colorado Blood Cancer Institute) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Cancer Center - (Colorado Blood Cancer Institute) conducted?

Sarah Cannon Cancer Center - (Colorado Blood Cancer Institute) has 1 clinical trials on record. Their work covers Relapsed/Refractory Multiple Myeloma (RRMM), Metastatic Colorectal Cancer (mCRC), Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Is Sarah Cannon Cancer Center - (Colorado Blood Cancer Institute) accredited by Crixeo Health?

Sarah Cannon Cancer Center - (Colorado Blood Cancer Institute) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Cancer Center - (Colorado Blood Cancer Institute)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.